- Report
- April 2025
- 271 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 473 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 274 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 74 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 181 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 110 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2024
- 240 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- May 2024
- 177 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- November 2024
- 172 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- June 2024
- 310 Pages
Global
From €4546EUR$4,995USD£3,861GBP
- Report
- September 2024
- 135 Pages
North America
From €3140EUR$3,450USD£2,667GBP
- Report
- September 2024
- 139 Pages
Middle East, Africa
From €3140EUR$3,450USD£2,667GBP
- Report
- September 2024
- 150 Pages
Europe
From €3140EUR$3,450USD£2,667GBP

Epilepsy is a neurological disorder characterized by recurrent seizures. It affects people of all ages and is one of the most common neurological disorders worldwide. Treatment options for epilepsy include medications, lifestyle changes, and surgery. The goal of treatment is to reduce the frequency and severity of seizures.
The epilepsy market is a subset of the larger neurology market. It is composed of pharmaceutical companies, medical device companies, and other healthcare providers. Pharmaceutical companies develop and market antiepileptic drugs (AEDs) to treat epilepsy. Medical device companies develop and market devices such as vagus nerve stimulators and responsive neurostimulators to treat epilepsy. Other healthcare providers, such as neurologists, provide diagnosis and treatment of epilepsy.
Some companies in the epilepsy market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Medtronic, Abbott, and UCB. Show Less Read more